Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB. [electronic resource]
Producer: 20130415Description: H567-78 p. digitalISSN:- 1522-1539
- Animals
- Antioxidants -- metabolism
- Cysteine Proteinase Inhibitors -- therapeutic use
- Diabetes Mellitus, Experimental -- complications
- Diabetes Mellitus, Type 1 -- complications
- Diabetic Cardiomyopathies -- diagnostic imaging
- Disease Models, Animal
- Female
- Gene Expression Regulation -- drug effects
- Hypertrophy, Left Ventricular -- drug therapy
- Leupeptins -- therapeutic use
- Mice
- Mice, Transgenic
- Myocarditis -- drug therapy
- NF-E2-Related Factor 2 -- physiology
- NF-kappa B -- physiology
- Oxidative Stress -- drug effects
- Proteasome Inhibitors -- therapeutic use
- Ultrasonography
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.